Tuesday, October 27, 2026

Back to today

How to Read a 10-K Like a Short Seller

A four-layer 10-K framework tests revenue timing, receivables, reserves and depreciation against cash flow, using Hertz’s 2012-14 accounting as a case study.

From X

@leevalueroach

Lee Roach on X

Clearwater Paper $CLW is a sitting duck for an aggressive activist. Stock is down 30% today. Management has zero at risk capital and all of the shares they own were given to them. No insider buys and only sells. Then this Stanford goofy comes in and buys their Augusta Mill for a ridiculously stupid valuation. He spent shareholders capital at the peak of the cycle for this capex pig at $1,184/ton. This mill has been a problem since day one and now is driving the stock down 30% today because they have to spend even more money on downtime for this POS. And then Mr. Arsen puts this POS in his header on LinkedIn. Only way they can realize value for this is by selling entire company or literally Arsen changing his name to Arson and torching this thing to the ground. The only thing Arsen is doing is torching shareholder capital here. There is no one stopping an activist here imo. Management owns 2% of the shares all from awards. No open market buys from insiders, only sells. Shareholders are visibly unhappy with say on pay support falling four years in a row and 2026 equity pay passed with only 54.5%. There is also no poison pill, all eight seats are up at the 2027 meeting and there is a fat change in control so management will get paid if you can get this dog shit sold. Also bank debt can be prepaid at par and that won't block a buyer. Suzano was exploring a bid in 2024 and Koch/Georgia-Pacific are logical buyers. Idea is to buy all the dog shit $CLW owns and shut it down and it fixes the oversupply in the market. Activist playbook is to buy a big block, flip the board, run a sales process and focus on capital discipline. I think you could sell this for $560/ton which is around $31/share, more than 2x current valuation. Management has blown their entire load on this dumb Augusta facility at the peak and it continues to cost shareholders who have at risk capital money. Management are employees who get paid no matter what happens. Activists should apply here. Fat pitch imo.

Unicycive (UNCY):

Unicycive’s oxylanthanum carbonate NDA earned a March 25, 2027 PDUFA date after two manufacturing-related rejections, with no FDA clinical…

BMBL 2026-10-21

Bumble is being taken private

Bumble agreed to a $6.05-per-share cash sale to Ithaca Holdings, 136% above its October 2 share price.

GLOO, part two

Gloo faces related-party deals, insider-heavy IPO ownership, acquisition losses and $84.5 million of CEO-backed puts as it burns cash and…

Carecloud News

CareCloud may attract a private-equity buyer after its Q3 call, with acquiring enough shares the main obstacle to a take-private deal.

LXS.DE: a 2028 sale it can force

Lanxess can force Advent to buy at least half its Envalior stake in April 2028, potentially raising about €745 million to reduce net debt.

Build-A-Bear: A Narrower Path

Build-A-Bear's push into prestuffed toys and broader retail distribution tests brand stretchability, but recent results warrant caution.

UNCY · long

Unicycive Therapeutics INC

Unicycive Therapeutics fell nearly 50% after a second FDA Complete Response Letter tied to a third-party manufacturer for its primary…

💥Yield!💥

Beyond Meat’s Q2 2026 revenue fell 8.2% as U.S. retail and foodservice volumes declined, while a flatter, not inverted, Treasury curve…

Updates

FGPR remains on track, PRTH's management buyout is set at $8.05, and microcap RAVE is described as cheap.

Is The Bond Market Running On Empty?

U.S. Treasury yields are testing credit and equity markets, while the discussion also targets recent changes at Glass House (GLAS).

IEH Corporation: Research Note

IEH booked $3.6 million in mobile-defibrillator connector orders, lifting its medical revenue outlook and diversifying beyond aerospace and…

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

X accounts we follow

Every account on this site, hand-picked.

91 accounts

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.